Brigham-born biotech startup testing food allergy drug
Startup ConsortiaTX finalized an agreement late last week to license a microbiome therapy from Brigham and Women's Hospital and Boston Children's Hospital.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Allison DeAngelis Source Type: news
More News: Allergy | Allergy & Immunology | American Health | Biotechnology | Children | Food Allergy | Health Management | Hospitals | Women